Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells.
Combining chemotherapy with radiation therapy may kill more tumor cells
PURPOSE: Randomized phase II trial to compare the effectiveness of three different regimens
of combining paclitaxel and carboplatin plus radiation therapy in treating patients who have
stage III non-small cell lung cancer that cannot be removed during surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Case Comprehensive Cancer Center
Collaborators:
American College of Radiology National Cancer Institute (NCI)